ARCH VENTURE FUND V, L.P. RE: XCYTE THERAPIES, INC.

Company

Bio Green Med Solution, Inc.

Filed

November 12, 2004

Accession Number

0000950135-04-005338

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →